from youarewithinthenorms.com

NORMAN J CLEMENT RPH., DDS, NORMAN L. CLEMENT PHARM-TECH, MALACHI F. MACKANDAL PHARMD, BELINDA BROWN-PARKER, IN THE SPIRIT OF JOSEPH SOLVO ESQ., INC., SPIRIT OF REV. IN THE SPIRIT OF WALTER R. CLEMENT BS., MS, MBA. HARVEY JENKINS, MD, PH.D., IN THE SPIRIT OF C.T. VIVIAN, JELANI ZIMBABWE CLEMENT, BS., M.B.A., IN THE SPIRIT OF THE HON. PATRICE LUMUMBA, IN THE SPIRIT OF ERLIN CLEMENT SR., EVELYN J. CLEMENT, IN THE SPIRIT OF WALTER F. WRENN III., MD., JULIE KILLINGSWORTH, RENEE BLARE, RPH, DR. TERENCE SASAKI, MD LESLY POMPY MD., CHRISTOPHER RUSSO, MD., NANCY SEEFELDT, IN THE SPIRIT OF WILLIE GUINYARD BS., JOSEPH WEBSTER MD., MBA, BEVERLY C. PRINCE MD., FACS., NEIL ARNAND, MD., IN THE SPIRIT OF RICHARD KAUL, MD., IN THE SPIRIT OF LEROY BAYLOR, JAY K. JOSHI MD., MBA, AISHA GARDNER, ADRIENNE EDMUNDSON, ESTER HYATT PH.D., WALTER L. SMITH BS., IN THE SPIRIT OF BRAHM FISHER ESQ., MICHELE ALEXANDER MD., CUDJOE WILDING BS, MARTIN NJOKU, BS., RPH., IN THE SPIRIT OF DEBRA LYNN SHEPHERD, BERES E. MUSCHETT, STRATEGIC ADVISORS

Smiling man with short gray hair wearing a red polo shirt against a gray background.

A close-up image of stacked papers with the headline 'Diversion of Truth' and subtitle 'An Investigation into the DEA’s War on American Pharmacies' highlighted in bold, set against a black and white background.

DR. DONALD L. SULLIVAN’S 50/50 LIE AND MYTH PLAYBOOK

DR. SULLIVAN’S BAD ETHICS REQUIRES LOSS OF LICENSURE AND ACADEMIC STANDING

“..Donald R. Sullivan, a Professor at the Ohio State University College of Pharmacy, never appears to have examined or interviewed the patients or prescribing physicians and relies on Junk Science in their courtroom testimony..”

Textual comparison highlighting a contradiction between the DEA's admission about lacking authority in medical guidelines and the reality of its practices imposing quantitative limits and overriding medical judgments. — The State Board of Pharmacies of Florida and Ohio must move for **vacatur** when the DEA substitutes its own “standard of care” or “reason to know” rules for the governing text of the CSA.

INTRODUCTION

The 5th Circuit’s landmark ruling in Neumann’s Pharmacy v. DEA(2026) marks a paradigm shift, providing a judicial rebuke to the DEA’s attempt to “quietly rewrite” existing regulations. The Court explicitly held that when the agency substitutes a different rule of decision for the governing text, its actions must be set aside as arbitrary and capricious.

This report was derived from the frequently discredited testimonies of government experts like Dr. Donald Sullivan (Ohio State University), to expose common failures:

Infographic titled 'The Shield of Auer Deference' discussing the DEA Administrative Court, highlighting blocked testimonies from prescribing physicians and actual patients, and denied standard civil litigation discovery processes.

A group of four men standing on a city sidewalk near a parking garage, engaged in conversation. Buildings and trees are visible in the background. — dea alpert, AUSA beerbower, LANGSTON IN pronto PHARMACY DEA ADMIN KANGAROO COURT HEARING, TAMPA, FL

DEA FAILED PHARMACY INVESTIGATION EXPOSED

A man smiling broadly, wearing a red polo shirt, against a gray background.

Misrepresentation of Law: In East Main Street Pharmacy(2010), the ALJ noted that Dr. Sullivan’s testimony regarding the “50/50 responsibility” split was “not a correct statement of the law.” This outlines the tactical objectives for cross-examination and motions in limine to expose the methodological failures of government experts who operate under a “presumption of guilt” rather than fact-based scientific principles.

Failure to Conduct Direct Inquiries: Experts frequently opine on “legitimate medical purpose” without interviewing the prescribing physicians or the patients.

Neglect of Primary Records: In Pronto Pharmacy LLC v. DEA(2020), Judge Mark D. Dowd explicitly found Dr. Sullivan’s opinion “improperly speculative and unjustified” because he failed to review relevant medical records or consider the prescriber’s justification.

Methodological Inconsistency: Experts often label red flags as “unresolvable” (asserting no explanation could warrant filling), but later concede under pressure that those same flags could be resolved with more information.

A dialogue excerpt from a cross-examination regarding pharmacy regulations, emphasizing questions about dispensary limitations and investigation details, marked by a 'FAILED' stamp.

OBJECTIVE

Immediate suspension, permanent revocation, academic suspension, and substantial monetary penalties for Dr.Donald L. Sullivan’s license to practice pharmacy by the State Board of Pharmacy of Florida(PS27060) and the Board of Pharmacy of Ohio(033183037).

A smiling man wearing a pink polo shirt, framed with a colorful background.

Dr. Sullivan and the D.E.A’s Playbook

The State Board of Pharmacies of Florida and Ohio must move for vacatur when the DEA substitutes its own “standard of care” or “reason to know” rules for the governing text of the CSA. When an expert’s factual foundation is proven non-existent, as was the case with Sullivan in Pronto 2019, of Tampa, Florida. (See Neuman vs. D.E.A)

BACKGROUND

These sources investigate allegations of regulatory overreach and systemic legal errors within the United States Drug Enforcement Administration (DEA), highlighting a successful legal challenge by Neumann’s Pharmacy, in which a federal court vacated a deregistration order because the agency misinterpreted its own rules regarding pharmacist liability and state standards of care additional excerpts offer a harsh critique of the agency’s dependence on “junk science” and expert witnesses like Dr. Donald Sullivan, a license pharmacist in the States of Ohio and Florida (see licensure verifications) whose testimony is accused of being speculative and factually unsupported.

An infographic discussing legal responsibilities in pharmacy, featuring Dr. Sullivan's courtroom testimony about the misconception of shared responsibility between pharmacists and physicians. It provides the actual federal law stipulations regarding pharmacist and physician duties. — This “50/50” claim suggests that if a prescription is found invalid, both the physician and the pharmacist automatically share apportioned liability.

A man smiling upside down, wearing a pink shirt, surrounded by a circular border.

THE FORM

DEA Targets Pharmacies, Not Cartels 15:41: MOVING THE GOALPOST, Donald R. Sullivan, a Professor at the Ohio State University College of Pharmacy, never appears to have examined or interviewed the patients or prescribing physicians, and relies on Junk Science in their courtroom testimony.

A critical strategic point is the contradiction found in judicial findings. In the Pronto case, Judge Dowd acknowledged that Dr. Sullivan’s opinion on certain prescriptions was “improperly speculative and unjustified” because he failed to review records.

Graphic detailing the involvement of Dr. Donald Sullivan, a Clinical Professor of Pharmacy, in drug diversion cases. Includes excerpts from a DEA judge's opinion criticizing his lack of review of medical records and reliance on speculative testimony.

In East Main Street Pharmacy 2010, of Columbus, Ohio, the ALJ noted that Dr. Sullivan’s testimony regarding the “50/50 responsibility” split was “not a correct statement of the law.”)

Strategic Directive for Defense Counsel: The State Board of Pharmacies of Florida and Ohio must move for vacatur when the DEA substitutes its own “standard of care” or “reason to know” rules for the governing text of the CSA. When an expert’s factual foundation is proven non-existent, as was the case with Sullivan in Pronto 2019, of Tampa, Florida.

Close-up portrait of a man with a light brown complexion, short hair, and a trimmed beard, wearing a black suit. — HAROLD EUGENE FLETCHER, PHARMD 2 YEARS FEDERAL PRISON BASED ON FRAUDULENT TESTAMONY OF DR. DONALD SULIVAN OF THE OHIO STATE UNIVERSITY

In East Main Street Pharmacy 2010, of Columbus, Ohio, the ALJ noted that Dr. Sullivan’s testimony regarding the “50/50 responsibility” split was “not a correct statement of the law.” —

Misrepresentation of Law: The case article alleges that the wrongful conviction of pharmacist Harold Eugene Fletcher and the targeting of Black-owned pharmacies stem from the fraudulent expert testimony of Dr. Donald Sullivan and systemic DEA corruption.

In East Main Street Pharmacy 2010, of Columbus, Ohio, the ALJ noted that Dr. Sullivan’s testimony regarding the “50/50 responsibility” split was “not a correct statement of the law.” —

Case file overview titled 'The Manufactured Scapegoat' detailing the subject James Barclay, the venue being U.S. District Court in Ohio, and the outcome of the indictment being dismissed unconditionally. Includes a quote and reality check about the prosecution's failure to meet standards. — Dr. Donald Sullivan, professor at the Ohio State University College of Pharmacy, working from home, was **used in both cases** as the Pharmacy Expert consultant and used “red flags” as a proxy to conclude the prescriptions were ‘illegitimate.’

A smiling man wearing a pink shirt, framed in a rounded graphic design.

Dr. Donald Sullivan, professor at the Ohio State University College of Pharmacy, working from home, was used in both cases (Miami-Luken) as the Pharmacy Expert consultant and used “red flags” as a proxy to conclude the prescriptions were ‘illegitimate.’

MIAMI-LUKEN, DAYTON, OHIO

Case: 1:19-cr-00081-MWM Doc #: 147 Filed: 08/02/22 Page: 1 of 2 PAGEID #: 1213 UNITED STATES OF AMERICA, Plaintiff, v. ANTHONY RATTINI et al., Defendants. CASE NO. 1:19-CR-81 JUDGE McFARLAND UNITED STATES DISTRICT COURT FOR THE SOUTHERN DISTRICT OF OHIO WESTERN DIVISION.

Infographic explaining the distinction between nociceptive and neuropathic pain, including their origins, targeted treatments, and the convergence of mixed pain. Highlights the importance of combining pharmacotherapy for greater pain reduction.

In both the cases of Pronto Pharmacy LLC and James Barclay et al., are similarly situated, and the nexus that Dr. Donald Sullivan, professor at the Ohio State University College of Pharmacy, working from home, was used in both cases as the Pharmacy Expert consultant and used “red flags” as a proxy to conclude the prescriptions were ‘illegitimate.’ (See Decision and Order, Fed. Reg. 86 FR 64714 (2021) id. at https://www.federalregister.gov/d/2021-25133/p-87) Dr. Sullivan’s entire testimony has lacked probity in courtrooms across America.

The Court in Neuman insists that the DEA cannot “quietly rewrite” the law to simplify its burden of proof. By enforcing Neumann’s requirement for subjective knowledge and bona fide practice, the court effectively dismantled the DEA’s administrative overreach.

Title card for the case Neumann's Pharmacy, L.L.C. v. Drug Enforcement Administration, including context about the case and the court's thesis regarding the DEA's authority and regulations, displayed on a decorative background.

FIFTH CIRCUIT REJECTED DEA’S CORRESPONDING RESPONSIBILITY OF PROFESSIONAL PRACTICE INTERPRETATIONS

Fifth Circuit Rejected DEA’s corresponding responsibility and usual course of profesional practice interpretations.Download

Informational graphic detailing the case file for Pronto Pharmacy LLC in Tampa, Florida, highlighting the lack of proof in the DEA's investigation and the revocation of its registration. — Detailing the case file for Pronto Pharmacy LLC in Tampa, Florida, highlighting the lack of proof in the DEA’s investigation and the revocation of its registration.

BREACH OF DUE PROCESS

A smiling man wearing a red polo shirt with short gray hair against a gray background.

MEET DR. DONALD SULLIVAN

In the Pronto case, Judge Dowd acknowledged that Dr. Sullivan’s opinion on certain prescriptions was “improperly speculative and unjustified” because he failed to review records. Yet, the judge maintained that this finding “does not affect the probity” of Sullivan’s other opinions.

A smiling man wearing a pink polo shirt, framed in a colorful background.

Diagram titled 'The Fraud of Subjective Expertise: An Audit of Dr. Donald Sullivan' comparing claims made by Dr. Sullivan with factual judicial findings. Contains three numbered claims and corresponding judicial realities, all marked 'REJECTED'. Includes quotes from DEA Judge Mark D. Dowd. — Donald R. Sullivan, Professor at Ohio State University College of Pharmacy, never appears to have examined or interviewed the patients or prescribing physicians and relies on Junk Science in their Courtroom testimonies.

ABUSE OF JUDICIAL PROCESS

DR.DONALD SULLIVAN’S ERRED TESTIMONY ON CORRESPONDING RESPONSIBILITY

The Legal Pillar: Corresponding Responsibility

“Excerpts present a scathing critique of the agency’s reliance on ‘junk science‘ and expert witnesses like Donald Sullivan, whose testimonies are accused of being speculative and factually unsupported.“

The regulatory cornerstone of pharmacy practice is the “Corresponding Responsibility” regulation, 21 C.F.R. § 1306.04(a). This regulation dictates that while the primary responsibility for prescribing rests with the physician, a corresponding responsibility rests with the pharmacist to ensure the prescription is valid.

A comparison chart detailing the DEA's claims versus the 5th Circuit Court rulings regarding prescription validity, liability of pharmacists, and reliance on prescribers, highlighting the discrepancies with 'FALSE' labels.

A common misconception—often perpetuated by “expert” witnesses—is the “50/50 responsibility” myth, which suggests that federal law apportions responsibility equally between the two. In reality, federal law imposes separate and independent duties on each practitioner.

A young child with curly hair holding an orange ball, looking thoughtfully in a courtroom setting with large windows and a judge's bench in the background. — The courts in Neumann (citing *Flores-Figueroa v. United States*) insist on a **subjective** standard. The government must prove the pharmacist had **actual knowledge**—or was “willfully blind”—to the prescription’s invalidity. As the court in *Neumann’s* noted, the DEA cannot “quietly rewrite” regulations by substituting “reason to know” for the explicit **“knowingly”** requirement found in the text.

“Knowingly“

Furthermore, as clarified in the landmark case Neumann’s Pharmacy v. DEA, a pharmacist cannot be held liable under this regulation unless the DEA first proves the prescription was invalid (issued outside the physician’s usual course of professional practice). Liability only attaches when a pharmacist knowingly fills such an invalid order.

Smiling man in a red polo shirt with short hair and a light complexion, posing against a gray background.

The “Sullivan 50/50 Myth”

A smiling man wearing a coral shirt, depicted inside a circular frame with a light green outline.

FEDERAL COURTS DISMANTLE D.E.A.PHARMACY TACTICS

The “50/50 Myth” vs. Legal Reality

A persistent misconception in regulatory enforcement—often promoted by DEA expert witnesses such as Donald Sullivan, R.Ph., Ph.D.—is that legal responsibility is split right down the middle.

This “50/50” claim suggests that if a prescription is found to be invalid, both the physician and the pharmacist automatically share an apportioned liability.

The following table debunks this myth by comparing expert testimony with the actual federal legal standards established by the courts.

Feature	The “Sullivan 50/50 Myth”	Federal Legal Reality
Allocation	Responsibility is apportioned (50% each).	Duties are separate and independent.
Legal Basis	Based on personal opinion and speculative “junk science.”	Based on 21 C.F.R. § 1306.04(a) and United States v. Hayes.
Scope of Duty	Suggests pharmacists must essentially second-guess medical diagnoses.	Pharmacists are not required to practice medicine; they must ensure the order is a valid “prescription.”
Source of Authority	Expert Witness Personal Opinion	21 C.F.R. § 1306.04(a) and Federal Case Law

Because these duties are independent, the law does not permit the DEA to assume a pharmacist is guilty simply because a doctor issued an improper order. To establish a prima facie violation, the government must pass a rigorous three-part legal test.

Under the precedents of Ruan v. United States and United States v. Moore, a practitioner acts within the usual course as long as they are acting “as a physician” or “as a pharmacist” in good faith. To violate the federal Controlled Substances Act, a practitioner must essentially cease acting as a medical professional and begin acting as a “pusher” or drug dealer. A negligent practitioner—a “bad pharmacist” by state standards—does not necessarily commit a federal CSA violation so long as they are operating within the bona fide operations of a pharmacy.

THE PHARMACOLOGICAL COCKTAIL vs. LAW ENFORCEMENT HOLY TRINITY

A diverse group of three medical professionals, including a Black man in ornate religious attire with a crown, a Hispanic male doctor in a lab coat, and a female doctor of Asian descent, all standing together with friendly expressions. — **PHARMACOLOGICAL COCKTAIL vs. Law Enforcement Holy TRINITY**

THE ANAND-BOREL-CLEMENT (ABC) PHARMACOLOGICAL TRINITY CONCEPT

Anand-Borel-Clement (ABC) Pharmacological Trinity Concept or The Pharmacological Cocktail: While opioids target G-protein-coupled receptors to block pain signals, benzodiazepines enhance GABAergic inhibition to provide necessary sedation and muscle relaxation. This pharmacological synergistic approach allows for lower medication doses, which effectively reduce adverse side effects while extending the duration of relief. Beyond clinical mechanics, law enforcement (DEA-DOJ, Prosecutors) have abused, misused, and misapplied this theological metaphor of the Holy Trinity, which is blasphemy, too Muslims, Hindus, and Christians, to illustrate how these distinct agents work in dynamic communion to heal the patient. Ultimately, the goal of this integrated therapy is to restore the individual’s equality of life, enabling them to return to employment, mobility, and social connection.

A row of red flags waving against a cloudy sky, with text overlay discussing red flags in relation to US Public Health Agency policy and treatment of pain. — Red Flags

Red Flags: Evidence, Not Automatic Violations

In enforcement actions, the DEA relies on “Red Flags”—indicators such as “drug cocktails” (e.g., opioids and benzodiazepines), out-of-pocket cash payments, or “therapeutic duplication.”

The Pharmacological Cocktail combination opioids target G-protein-coupled receptors to block pain signals, benzodiazepines enhance GABAergic inhibition to provide necessary sedation and muscle relaxation. This pharmacological synergistic approach allows for lower medication doses, which effectively reduce adverse side effects while extending the duration of relief.

Illustration explaining how benzodiazepines enhance the GABAergic inhibitory response, showing the binding of benzodiazepines to the GABA_A receptor, the mechanism of chloride ion influx across neuronal synapses, and the resulting systemic sedation and muscle relaxation. — This pharmacological synergistic approach allows for lower medication doses, which effectively reduce adverse side effects while extending the duration of relief.

Shocking truth about benzodiazepine withdrawal AND THE DANGERS OF PRACTICING MEDICINE

L. Joseph Parker, a research physician, delves into a recent comparative effectiveness study that examines the effects of discontinuing long-term benzodiazepine therapy on patient mortality and adverse events. This study specifically looks at how baseline opioid exposure may impact the outcomes of patients undergoing benzodiazepine discontinuation. Through this exploration, we will uncover the study’s key findings, discuss the implications for clinical practice, and outline the potential risks and benefits of discontinuing benzodiazepine therapy in patients receiving stable long-term treatment. This research sheds light on an important aspect of patient care and provides valuable insights for healthcare providers. If you are interested in understanding the impact of benzodiazepine discontinuation on patient mortality and adverse events, especially in the context of baseline opioid exposure, this video is a must-watch. Stay informed, stay educated, and join us as we explore the fascinating world of comparative effectiveness studies in healthcare.

Beyond clinical mechanics, law enforcement (DEA-DOJ, Prosecutors) have abused, misused, and misapplied this theological metaphor of the Holy Trinity, which is blasphemy, too Muslims, Hindus, and Christians, to illustrate how these distinct agents work in dynamic communion to heal the patient. Ultimately, the goal of this integrated therapy is to restore the individual’s equality of life, enabling them to return to employment, mobility, and social connection.

Image featuring a title and subtitle discussing the Red Flag Doctrine and its implications on American pharmacies, with a red stamp reading 'EVIDENCE FILE: DEA-2019-WM'. — RED FLAG DOCTRINE DEA NEUMAN, PRONTO, SUPERIOR, LINCOURT PHARMACIES, DRS. LESLY POMPY, MD, TERANCE SASAKI, MD, LINDA CHEEK, MD., CASH, TRAVEL, MANUFACTURE, RED FLAG FILTERED

While these are indicators that a prescription might be invalid, the DEA often commits a legal error by treating red flags as automatic proof of a violation. In Neumann’s Pharmacy, the DEA even attempted to apply a Louisiana law—which prohibits physicians from prescribing to family members—to a pharmacist who filled such a script, illustrating a clear overreach in applying state-specific professional bans to federal dispensers.

A field dotted with small red flags, accompanied by text highlighting that these flags represent errors in US Public Health Agency policy regarding pain treatment. — These flags indicate errors in the US Public Health Agency’s policy on pain treatment.

Furthermore, red flags can often be resolved through professional inquiry. The DEA’s reliance on these indicators is frequently criticized when it lacks a factual foundation, as seen in the critique of expert testimony in the Pronto Pharmacy case:

“An expert… must base his knowledge on more than ‘subjective belief or unsupported speculation.’ … I question the sufficiency of the factual foundation for Dr. Sullivan’s expert opinion… I find Dr. Sullivan’s subject opinion, on the basis of this record, to be improperly speculative and unjustified as an expert opinion.” — DEA Judge Mark D. Dowd, In the Matter of Pronto Pharmacy, LLC

Flowchart illustrating the legal responsibilities of pharmacists regarding prescription filling, highlighting three gates: Filling, Invalidity, and Knowledge, with a case example concerning Neumann's Pharmacy. — The most significant point of contention in DEA enforcement is the definition of “knowledge.” The DEA frequently attempts to apply an **objective** “reason to know” standard, arguing that a pharmacist is liable if they *should* have suspected an issue.

RED FLAG CRIMINALIZATION OF PAIN CARE:

The Status (Invalidity): The prescription must have been invalid at the moment it was issued. Crucially, the Neumann court held that the DEA cannot find a pharmacist liable without first proving that the prescribing physician acted outside the “usual course of professional practice.”

A young boy with dark hair and wearing a beige sweater looks thoughtfully at the camera, with a grand building featuring columns in the background. — Following the *Flores-Figueroa principle*, the court uses the “child and the toy” analogy: if a child knowingly takes a sibling’s toy, the child must know not only that they are taking an object, but that the object *belongs to the sibling*.

ARUGUMENT

The “Transitive Verb” Argument and Flores-Figueroa Under Neumann’s, “knowingly” is a modifier for the transitive verb “fills” and its object “invalid prescription.” Following the Flores-Figueroa principle, the court uses the “child and the toy” analogy: if a child knowingly takes a sibling’s toy, the child must know not only that they are taking an object, but that the object belongs to the sibling.

An informative graphic discussing federal felonies, focusing on the significance of the adverb 'knowingly' in legal context, including excerpts from a Supreme Court case and key takeaways for pharmacists regarding liability. — Discussing federal felonies, focusing on the significance of the adverb ‘knowingly’ in legal context, including excerpts from a Supreme Court case and key takeaways for pharmacists regarding liability.

Grammatically, the DEA must prove the pharmacist had subjective knowledge of the invalidity of the prescription at the time of dispensing. This creates a significantly higher burden of proof than the “reason to know” standard the DEA prefers to apply.

A comparison of the DEA's flawed standard against the Supreme Court standard in the case Ruan v. United States. The image highlights issues such as subjective guessing, remote evaluations, and presuming guilt without intent, contrasted with the Court's requirement for proof of knowledge regarding prescriptions. — A comparison of the DEA’s flawed standard against the Supreme Court standard in the case Ruan v. United States. The image highlights issues such as subjective guessing, remote evaluations, and presuming guilt without intent, contrasted with the Court’s requirement for proof of knowledge regarding prescriptions.

The Three-Part Test for Pharmacist Liability

Following the appellate ruling in Neumann’s Pharmacy v. DEA, federal courts have clarified that for liability to attach under 21 C.F.R. § 1306.04(a), three specific conditions must be met:

1. The Act (Filling): The pharmacist must have actually dispensed the controlled substance.

2.The Status (Invalidity): The prescription must have been invalid at the moment it was issued. Crucially, the Neumann’s court held that the DEA cannot find a pharmacist liable without first proving that the prescribing physician acted outside the “usual course of professional practice.”

3.The Intent (Knowledge): The pharmacist must have filled the prescription knowingly.

The “Knowledge” Requirement: Subjective vs. Objective

The most significant point of contention in DEA enforcement is the definition of “knowledge.” The DEA frequently attempts to apply an objective “reason to know” standard, arguing that a pharmacist is liable if they should have suspected an issue.

However, the courts (citing Flores-Figueroa v. United States) insist on a subjective standard. The government must prove the pharmacist had actual knowledge—or was “willfully blind”—to the prescription’s invalidity. As the court in Neumann’s noted, the DEA cannot “quietly rewrite” regulations by substituting “reason to know” for the explicit “knowingly” requirement found in the text.

Infographic titled 'Enforcing the Boundaries' outlining three areas of focus: For the Courts, detailing 'The Neumann Blueprint' which demands statutory textualism and accountability for the DEA; For Medical Advocates, highlighting 'The AMA Mandate' emphasizing the rejection of certain opioid prescription policies; and For Congress, mentioning 'The Accountability Check' calling for investigations into the DEA's practices and use of algorithms.

Final Statement: The pharmacist serves as a vital gatekeeper in the healthcare system, yet they must be protected by a clear application of the law; administrative agencies cannot be permitted to substitute speculative expert testimony for the established requirements of scienter and professional practice.

WHEREFORE, this article serves notice to the State of Florida and the State of Ohio Pharmacy Licensing Boards of a complaint alleging Donald L. Sullivan is a public health danger through his years of misrepresentation, fraudulent testimonies, in violation of his licensure as a Pharmacist, as we have highlighted here in this article, and a proper investigation must be is neccessary and must be opened.

Norman J. Clement, RPh, DDS:

50/50 CONCEPT

I want to thank you, Dr. Donald L. Sullivan of The Ohio State University for activating my scientific research genes and giving me the knowledge and wisdom to counter your misinformation of junk science. Most importantly, Dr. Sullivan, teach those my 50/50 concept who have fallen victim to your professed profound stupidity;